Skip to main content
All lobbying filings

RAI SERVICES COMPANY

Lobbying for RAI SERVICES COMPANY

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$1,850,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 12
  • Agriculture, Dept of (USDA)
  • Commerce, Dept of (DOC)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • Office of Management & Budget (OMB)
  • SENATE
  • Treasury, Dept of
  • U.S. Customs & Border Protection
  • U.S. International Trade Commission (ITC)
  • U.S. Trade Representative (USTR)
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 4
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • S 464
    No Tax Subsidies for E-Cigarette and Tobacco Ads Act
  • S 2929
    Tobacco Tax Equity Act of 2023
  • HR 5715
    Tobacco Tax Equity Act of 2023
 Lobbying activity 6
Tobacco

Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA, PMTA, and MRTP compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes Issues surrounding increased scrutiny on FDA/CTP for delayed enforcement Issues surrounding CBP resources for interdicting massive influx & mislabeling illicit vapes Issues surrounding retail inspections enforcement limitation Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes January 2025 Proposed Rule: Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency

Trade (domestic/foreign)

Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs); H.R. 1, One Big Beautiful Bill Act

Budget/Appropriations

Discussions concerning the FY 2025 and FY 2026 appropriations bills; provisions related to the FDA regulation of tobacco

Agriculture

Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis

Government Issues

Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis

Taxation/Internal Revenue Code

S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes. Issues surrounding taxation of tobacco products

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem